FDA Inspection
Seraplex IncSeraplex Inc – FDA Inspection, Mar 8, 2024
Record Details
This FDA Inspection record concerns Seraplex Inc, with an inspection on March 8, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c0111a88-9540-4b48-8dbb-22b53fd4a678
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1232805
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Seraplex Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 25, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Seraplex Inc
- FDA Inspection 1084988 - 2019-03-22
- FDA Inspection 792878 - 2012-07-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.